Fast-acting approaches for treatment-resistant depression: real-world comparative effectiveness of Intranasal Esketamine versus accelerated rTMS.
Int J Psychiatry Clin Pract March 11, 2026 Peer reviewed DOI: 10.1080/13651501.2026.2642680 via PubMed
Summary
Intranasal Esketamine and accelerated repetitive Transcranial Magnetic Stimulation (rTMS) are both effective treatments for individuals with treatment-resistant depression. The study compares the real-world effectiveness of these two fast-acting therapies, highlighting their potential benefits for patients who do not respond to traditional treatments.
Study at a glance
| Population | individuals with treatment-resistant depression |
|---|
Abstract
Fast-acting approaches for treatment-resistant depression: real-world comparative effectiveness of Intranasal Esketamine versus accelerated rTMS.